Synoptic reporting
Chances and challenges for secondary use of pathology data in biobanking
- 08.12.2025
- Hauptreferate: Hauptprogramm der DGP – Kurzbeiträge
Erschienen in:
- Verfasst von
- Julian Dörenberg, M.Sc.
- Erschienen in
- Die Pathologie | Sonderheft 1/2026
Abstract
Background
A high quality of biosample-associated data (DQ) is critical for biomedical research. Synoptic reporting (SR) provides the chance to increase DQ for the secondary use of data from surgical pathology (SP) in Germany. Hence, it is of high interest for biobanks that data-providing SP departments force the implementation of SR.
Materials and methods
Results
Successful use of SR requires efforts from SP departments as well as from biobanks. Firstly, it requires revision of processes in SP departments. This also applies to the similar tissue assessment processes in biobanks. Secondly, biobanks need to prepare by implementing the required standards such as FHIR and SNOMED CT.
Conclusion
Common efforts in SP departments and biobanks are required to facilitate the utmost benefits of SR for DQ in patient care and research. Biobanks can serve as a platform for SP departments to attempt new processes that implement SR and can provide independent feedback on DQ in SP departments.
Anzeige
- Titel
-
Synoptic reporting
Chances and challenges for secondary use of pathology data in biobanking - Verfasst von
-
Julian Dörenberg, M.Sc.
- Publikationsdatum
- 08.12.2025
- Verlag
- Springer Medizin
- Erschienen in
-
Die Pathologie / Ausgabe Sonderheft 1/2026
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196 - DOI
- https://doi.org/10.1007/s00292-025-01505-y
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
